Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
325,018
-
Share change
-
-9,184
-
Total reported value
-
$1,000,270
-
Price per share
-
$3.08
-
Number of holders
-
17
-
Value change
-
-$28,356
-
Number of buys
-
4
-
Number of sells
-
6
Institutional Holders of ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) as of Q4 2025
As of 31 Dec 2025,
ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
325,018 shares.
The largest 10 holders included
Twin Lakes Capital Management, LLC, MORGAN STANLEY, HB Wealth Management, LLC, GREENLEAF TRUST, CITADEL ADVISORS LLC, BNP PARIBAS FINANCIAL MARKETS, ACADIAN ASSET MANAGEMENT LLC, RHUMBLINE ADVISERS, GAMMA Investing LLC, and OSAIC HOLDINGS, INC..
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.